1. Home
  2. VYGR vs PMM Comparison

VYGR vs PMM Comparison

Compare VYGR & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Logo Putnam Managed Municipal Income Trust

PMM

Putnam Managed Municipal Income Trust

HOLD

Current Price

$6.22

Market Cap

264.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
PMM
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
222.4M
264.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
PMM
Price
$3.89
$6.22
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
667.5K
118.3K
Earning Date
03-10-2026
01-01-0001
Dividend Yield
N/A
4.68%
EPS Growth
N/A
N/A
EPS
N/A
0.23
Revenue
$31,316,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$71.78
N/A
P/E Ratio
N/A
$26.52
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$5.00
52 Week High
$5.78
$6.42

Technical Indicators

Market Signals
Indicator
VYGR
PMM
Relative Strength Index (RSI) 45.43 51.91
Support Level $3.86 $6.12
Resistance Level $4.11 $6.27
Average True Range (ATR) 0.25 0.07
MACD 0.01 -0.01
Stochastic Oscillator 47.79 45.83

Price Performance

Historical Comparison
VYGR
PMM

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: